Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Curtiss

Showing results (121-130 of 351) with videos related to

Pageof 36
Sort By:
Journal of Managed Care Pharmacy : JMCP|September 20, 2006
Pharmacy benefit spending on oral chemotherapy drugsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 7, 2006
What is the future of thiazolidinediones (TZDs) after market introduction of inhaled insulin?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 8, 2007
Atopic march to a dead end or does the theory really have legs?Frederic R Curtiss
Gastrointestinal Endoscopy|January 1, 1997
Esophageal tattoo from ingested capsuleJ R Curtiss
Journal of Managed Care Pharmacy : JMCP|April 29, 2008
HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACSFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
The relative value of disease management programs versus drug manufacturer rebatesFrederic R Curtiss
American Journal of Hospital Pharmacy|April 1, 1984
Final regulations on Medicare prospective pricingF R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Selectivity and specificity are the keys to cost-effective use of omalizumab for allergic asthmaFrederic R Curtiss
Topics in Hospital Pharmacy Management|April 11, 1982
Reimbursement for clinical pharmacy servicesF R Curtiss
American Journal of Hospital Pharmacy|August 1, 1988
Recent developments in federal reimbursement for home health-care services and productsF R Curtiss
Pageof 36

Showing results (121-130 of 351) with videos related to

Sort By:
Pageof 36
Journal of Managed Care Pharmacy : JMCP|September 20, 2006
Pharmacy benefit spending on oral chemotherapy drugsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 7, 2006
What is the future of thiazolidinediones (TZDs) after market introduction of inhaled insulin?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 8, 2007
Atopic march to a dead end or does the theory really have legs?Frederic R Curtiss
Gastrointestinal Endoscopy|January 1, 1997
Esophageal tattoo from ingested capsuleJ R Curtiss
Journal of Managed Care Pharmacy : JMCP|April 29, 2008
HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACSFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
The relative value of disease management programs versus drug manufacturer rebatesFrederic R Curtiss
American Journal of Hospital Pharmacy|April 1, 1984
Final regulations on Medicare prospective pricingF R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Selectivity and specificity are the keys to cost-effective use of omalizumab for allergic asthmaFrederic R Curtiss
Topics in Hospital Pharmacy Management|April 11, 1982
Reimbursement for clinical pharmacy servicesF R Curtiss
American Journal of Hospital Pharmacy|August 1, 1988
Recent developments in federal reimbursement for home health-care services and productsF R Curtiss
Pageof 36